Borman, 1987 - Google Patents
Analytical biotechnology of recombinant productsBorman, 1987
- Document ID
- 17578462610252941543
- Author
- Borman S
- Publication year
- Publication venue
- Analytical chemistry
External Links
Snippet
The biotechnological revolution has created many new challenges and op portunities in analytical chemistry. A number of these challengesinvolve the monitoring of raw materials, in- process intermediates, and final products in the commercial production of pharmaceuticals …
- 238000000034 method 0 abstract description 38
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/746—Erythropoetin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/447—Systems using electrophoresis
- G01N27/44704—Details; Accessories
- G01N27/44743—Introducing samples
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Garnick et al. | The role of quality control in biotechnology: An analytical perspective | |
| Sirrenberg et al. | Carrier protein import into mitochondria mediated by the intermembrane proteins Tim10/Mrs11 and Tim12/Mrs5 | |
| Hosoda et al. | Protein synthesis by Escherichia coli infected with bacteriophage T4D | |
| Marshall et al. | Human serum proteins preseparated by electrophoresis or chromatography followed by tandem mass spectrometry | |
| BR9809443A (en) | Polypeptide comprising an antigenic portion of an antigen of m. tuberculosis, dna molecule, recombinant expression vector, host cell, process for detection of m. tuberculosis in a biological sample, diagnostic kit, monoclonal antibody, polyclonal antibody, and fusion protein. | |
| US6451591B1 (en) | Device and method for the determination of protein domain boundaries | |
| Oliver | HPLC of macromolecules: a practical approach | |
| BR9712298A (en) | Polypeptide, DNA molecule, recombinant expression vector, host cell, process to detect infection by m. tuberculosis in a biological sample, diagnostic kit, monoclonal, and, polyclonal, and, fusion protein | |
| US5731157A (en) | Two-site allergen immunoassay | |
| Borman | Analytical biotechnology of recombinant products | |
| Bond | An in vitro binding assay for angiogenin using placental ribonuclease inhibitor | |
| US10261081B2 (en) | Low density microarrays for vaccine related protein quantification, potency determination and efficacy evaluation | |
| US20070184504A1 (en) | Assay for anti-INGAP antibodies | |
| Scopes | Overview of protein purification and characterization | |
| Anicetti et al. | Analytical considerations in the development of protein purification processes | |
| Scopes et al. | Analysis of proteins | |
| US8178344B2 (en) | System and method for antigen structure-independent detection of antigens captured on antibody arrays | |
| Van Bogelen et al. | Application of two-dimensional protein gels in biotechnology | |
| Garnick et al. | Recombinant DNA Manufacture | |
| Nelson et al. | Isolation of protein subpopulations undergoing protein-protein interactions | |
| Jones et al. | Quality control of rDNA-derived human tissue-type plasminogen activator | |
| Garnick | Safety aspects in the quality control of recombinant products from mammalian cell culture | |
| Qin et al. | A new strategy of studying protein–protein interactions: Integrated strong anion exchange/reversed‐phase chromatography/immunoprecipitation coupled with mass spectrometry for large‐scale identification of proteins interact with immunoglobulin G in HeLa cells | |
| Ban et al. | Detection of recombinant hirudin using capillary electrophoresis with laser-induced fluorescence detection | |
| Hardin et al. | Cloning, gene expression, and protein purification |